Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: A 30-day, randomized, double-masked, artificial tear substitute-controlled trial
- 30 September 2005
- journal article
- clinical trial
- Published by Elsevier BV in Clinical Therapeutics
- Vol. 27 (9), 1392-1402
- https://doi.org/10.1016/j.clinthera.2005.09.013
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Efficacy and safety of ketotifen eye drops in the treatment of seasonal allergic conjunctivitisBritish Journal of Ophthalmology, 2003
- Comparative study of 0.1% olopatadine hydrochloride and 0.5% ketorolac tromethamine in the treatment of seasonal allergic conjunctivitisActa Ophthalmologica Scandinavica, 2003
- Ketotifen fumarate and olopatadine hydrochloride in the treatment of allergic conjunctivitis: A real-world comparison of efficacy and ocular comfortAdvances in Therapy, 2003
- In Vitro Inhibition of Human Conjunctival Mast-Cell Degranulation by KetotifenJournal of Ocular Pharmacology and Therapeutics, 2003
- Update on ocular allergy treatmentExpert Opinion on Pharmacotherapy, 2002
- Tear and conjunctival changes during the allergen-induced early- and late-phase responsesJournal of Allergy and Clinical Immunology, 2000
- A comparison of the relative efficacy and clinical performance of olopatadine hydrochloride 0.1% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the conjunctival antigen challenge modelClinical Therapeutics, 2000
- Evaluation of Olopatadine, a New Ophthalmic Antiallergic Agent with Dual Activity, Using the Conjunctival Allergen Challenge ModelAnnals of Allergy, Asthma & Immunology, 1998
- A flow cytometric study about the immunopathology of vernal keratoconjunctivitisJournal of Allergy and Clinical Immunology, 1998
- Flow cytometry tear analysis in patients with chronic allergic conjunctivitisJapanese Journal of Ophthalmology, 1997